Aflac Incorporated (NYSE:AFL) Shares Sold by Amalgamated Bank

Amalgamated Bank reduced its holdings in shares of Aflac Incorporated (NYSE:AFL) by 2.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 100,452 shares of the financial services provider’s stock after selling 2,899 shares during the quarter. Amalgamated Bank’s holdings in Aflac were worth $10,391,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Darwin Wealth Management LLC purchased a new position in shares of Aflac during the 3rd quarter worth approximately $34,000. BankPlus Trust Department acquired a new stake in Aflac during the 4th quarter valued at $34,000. Raelipskie Partnership purchased a new position in Aflac during the third quarter worth $38,000. Covestor Ltd increased its position in Aflac by 41.8% during the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after buying an additional 107 shares in the last quarter. Finally, Kennebec Savings Bank acquired a new position in shares of Aflac in the third quarter worth $45,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Insider Activity at Aflac

In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the firm’s stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the transaction, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at $23,018,701.20. This trade represents a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.80% of the company’s stock.

Aflac Stock Performance

Shares of NYSE:AFL opened at $106.77 on Wednesday. The firm has a market capitalization of $59.31 billion, a PE ratio of 11.12, a P/E/G ratio of 3.24 and a beta of 0.99. Aflac Incorporated has a 12 month low of $78.62 and a 12 month high of $115.50. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. The business has a 50-day moving average of $104.19 and a two-hundred day moving average of $107.47.

Aflac (NYSE:AFL) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, research analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Wednesday, February 19th will be paid a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.17%. The ex-dividend date is Wednesday, February 19th. This is an increase from Aflac’s previous quarterly dividend of $0.50. Aflac’s dividend payout ratio (DPR) is currently 24.17%.

Analyst Ratings Changes

A number of analysts recently commented on the company. Truist Financial lifted their price objective on Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a report on Friday, February 14th. Wells Fargo & Company reduced their price objective on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 19th. Evercore ISI lowered their target price on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research note on Wednesday, December 4th. Finally, BMO Capital Markets began coverage on Aflac in a research note on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $102.86.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.